AAB
RPRX icon

ABN AMRO Bank’s Royalty Pharma RPRX Stock Holding History

ABN AMRO Bank’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Sell
19,985
-5,080
-20% -$264K 0.01% 156
2026
Q1 		$1.21M Sell
25,065
-10,429
-29% -$457K 0.01% 151
2025
Q4 		$1.38M Sell
35,494
-3,206
-8% -$122K 0.01% 151
2025
Q3 		$1.36M Buy
38,700
+4,306
+13% +$156K 0.01% 153
2025
Q2 		$1.24M Sell
34,394
-1,950
-5% -$64.6K 0.02% 114
2025
Q1 		$1.13M Buy
+36,344
New +$1.15M 0.02% 117

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ABN AMRO Bank's RPRX Position: Q2 2026 in Review

ABN AMRO Bank reduced its Royalty Pharma (RPRX) stake by 20% in Q2 2026, selling an estimated $264K and leaving 19,985 shares worth $1.12M. The position accounts for 0.01% of the portfolio, ranked #156.

ABN AMRO Bank first reported a position in RPRX in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.38M in Q4 2025. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • ABN AMRO Bank held 19,985 shares of Royalty Pharma worth $1.12M as of Q2 2026.
  • ABN AMRO Bank sold 5,080 Royalty Pharma shares in Q2 2026, an estimated $264K.
  • Royalty Pharma made up 0.01% of ABN AMRO Bank's portfolio in Q2 2026, its #156 holding.
  • ABN AMRO Bank first reported a position in Royalty Pharma in Q1 2025 and has held it in 6 quarters since.
  • ABN AMRO Bank's Royalty Pharma position peaked at $1.38M in Q4 2025.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on ABN AMRO Bank's 13F filing for Q2 2026, filed 6 Aug 2026.